Number of partners
University of British Columbia, Vancouver, British Columbia
former partner, PriceWaterhouse Cooper LLP and former Assistant Auditor General of Canada
With one in six children impacted by neurodevelopmental disorders such as cerebral palsy, autism and fetal alcohol spectrum disorders (FASD), there is an enormous need to improve diagnostic capabilities, develop new interventions, introduce new clinical practices, and better support affected children and their families. Canada was already known globally for its excellence in neuroscience and brain-related research. The next step was to create a national network that enabled researchers, neurological institutes and children’s hospitals from across the country to collaborate on new ways to treat, cure or prevent brain dysfunction in unborn children, and help children and their families overcome the challenges of neurodevelopmental disorders.
NeuroDevNet researchers from multiple scientific disciplines collaborate with community, industry, government and not-for-profit partners to understand the genetic and environmental causes of cerebral palsy, autism and fetal alcohol spectrum disorders. The network supports high-impact and transformative research, and the translation of this research into tangible benefits, and provides innovative training opportunities to seed a new generation of highly skilled Canadian researchers. This collaborative effort is providing health care professionals, policy makers, caregivers and families with tools and information to promote earlier diagnosis, better treatment, and optimal outcomes for children today, and in the future.